Hepatic encephalopathy and depression in chronic liver disease: is the common link systemic inflammation?

Area of Science:

• Gastroenterology and Hepatology
• Neuroscience
• Psychiatry

Background:

• Hepatic encephalopathy and depression present overlapping clinical features like cognitive impairment in chronic liver disease.
• Both conditions are associated with poor prognosis, increased mortality, and reduced quality of life.
• Systemic inflammation and gut dysbiosis are implicated in the pathophysiology of both conditions.

Purpose of the Study:

• To explore the shared pathophysiology between hepatic encephalopathy and depression in patients with chronic liver disease.
• To investigate the potential role of gut dysbiosis and inflammation in the co-occurrence of these conditions.
• To evaluate the emerging evidence for psychobiotics as a potential dual therapeutic intervention.

Main Methods:

• Review of existing literature on hepatic encephalopathy, depression, systemic inflammation, and gut microbiota in chronic liver disease.
• Analysis of shared clinical features and pathophysiological mechanisms.
• Examination of studies investigating psychobiotic interventions.

Main Results:

• Hepatic encephalopathy and depression share clinical manifestations and pathophysiological drivers, including hyperammonaemia, systemic inflammation, and gut dysbiosis.
• Gut dysbiosis may contribute to increased bacterial translocation, fueling shared inflammatory pathways.
• Preliminary evidence suggests psychobiotics could potentially improve both cognitive function and mood.

Conclusions:

• Hepatic encephalopathy and depression exhibit significant overlap in clinical presentation and underlying pathophysiology in chronic liver disease.
• Gut dysbiosis and inflammation are critical factors linking these two conditions.
• Psychobiotics represent a promising therapeutic avenue for simultaneously addressing cognitive and mood disturbances in this patient population.